Skip to main content

Table 3 Correlations between inflammatory biomarkers and endoscopic IBD activity and clinical measures

From: Platelet/Albumin ratio and plateletcrit levels are potential new biomarkers for assessing endoscopic inflammatory bowel disease severity

 

UC

 

CD

Mayo

SCCAI

 

SES-CD

HBI

hs-CRP (mg/L)

0.198*

0.183*

 

0.313**

0.18

ESR (mm/hr)

0.169

0.135

 

0.298**

0.241**

WBC × 109/L

0.104

0.206*

 

0.258**

0.115

FIB (g/L)

0.099

0.219*

 

0.234**

0.132

PCT (%)

0.035

0.049

 

0.357**

0.097

PLT × 109/L

0.231**

0.280**

 

0.303**

0.102

ALB (g/L)

−0.298**

−0.262**

 

−0.092

−0.291**

NLR

0.075

−0.128

 

0.122

0.135

PLR

0.036

0.012

 

0.115

0.081

PLT/ALB

0.293**

0.277**

 

0.284**

0.195*

  1. *p < 0.05, **p < 0.01, and p < 0.05 values were considered statistically significant (bold)
  2. Endoscopic IBD activity and clinical measures: Mayo scores for UC and SES-CD for CD and SCCAI for UC and HBI for CD
  3. Abbreviations: SCCAI, Simple Clinical Colitis Activity Index; SES-CD,Simplified Endoscopic Scores for CD; HBI, Harvey Bradshaw Index; hs-CRP, high sensitive C-reactive protein; ESR, erythrocyte sedimentation rate; WBC, white blood cell; FIB, fibrinogen; PLT, platelet; PCT, plateletcrit; ALB, Albumin; NLR, neutrophil-to-lymphocyte ratio; PLR, platelet-to-lymphocyte ratio; PLT/ ALB, platelet-to-albumin ratio
Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us